These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 16903867)

  • 1. Large-scale expansion of rat CD4+ CD25+ T(reg) cells in the absence of T-cell receptor stimulation.
    Beyersdorf N; Balbach K; Hünig T; Kerkau T
    Immunology; 2006 Dec; 119(4):441-50. PubMed ID: 16903867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis.
    Beyersdorf N; Gaupp S; Balbach K; Schmidt J; Toyka KV; Lin CH; Hanke T; Hünig T; Kerkau T; Gold R
    J Exp Med; 2005 Aug; 202(3):445-55. PubMed ID: 16061730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TCR-independent activation of human CD4+ 45RO- T cells by anti-CD28 plus IL-2: Induction of clonal expansion and priming for a Th2 phenotype.
    Brinkmann V; Kinzel B; Kristofic C
    J Immunol; 1996 Jun; 156(11):4100-6. PubMed ID: 8666775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a CD4+CD25+ T cell subset committed in vivo to suppress antigen-specific T cell responses without additional stimulation.
    Nolte-'t Hoen EN; Wagenaar-Hilbers JP; Boot EP; Lin CH; Arkesteijn GJ; van Eden W; Taams LS; Wauben MH
    Eur J Immunol; 2004 Nov; 34(11):3016-27. PubMed ID: 15376196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
    Chen HW; Liao CH; Ying C; Chang CJ; Lin CM
    Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superagonistic anti-CD28 antibodies: potent activators of regulatory T cells for the therapy of autoimmune diseases.
    Beyersdorf N; Hanke T; Kerkau T; Hünig T
    Ann Rheum Dis; 2005 Nov; 64 Suppl 4(Suppl 4):iv91-5. PubMed ID: 16239397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
    Pyzik M; Piccirillo CA
    J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.
    Ahn JS; Krishnadas DK; Agrawal B
    Int Immunol; 2007 Mar; 19(3):227-37. PubMed ID: 17289657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4+ CD25+ [corrected] regulatory T cells render naive CD4+ CD25- T cells anergic and suppressive.
    Qiao M; Thornton AM; Shevach EM
    Immunology; 2007 Apr; 120(4):447-55. PubMed ID: 17244157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of bone marrow stromal cells in the generation of human CD8+ regulatory T cells.
    Poggi A; Zocchi MR
    Hum Immunol; 2008 Nov; 69(11):755-9. PubMed ID: 18817823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vitro generation and characterisation of murine CD4+CD25+ regulatory T cells with indirect allospecificity.
    Tsang J; Jiang S; Tanriver Y; Leung E; Lombardi G; Lechler RI
    Int Immunopharmacol; 2006 Dec; 6(13-14):1883-8. PubMed ID: 17161341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of IL-6, IL-1, and CD28 signaling in responses of mouse CD4+ T cells to immobilized anti-TCR monoclonal antibody.
    Holsti MA; McArthur J; Allison JP; Raulet DH
    J Immunol; 1994 Feb; 152(4):1618-28. PubMed ID: 7907103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4+CD25+ regulatory T cells are activated in vivo by recognition of self.
    Andersson J; Stefanova I; Stephens GL; Shevach EM
    Int Immunol; 2007 Apr; 19(4):557-66. PubMed ID: 17369190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Requirement of CD28 signaling in homeostasis/survival of TGF-beta converted CD4+CD25+ Tregs from thymic CD4+CD25- single positive T cells.
    Liu Y; Amarnath S; Chen W
    Transplantation; 2006 Oct; 82(7):953-64. PubMed ID: 17038912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quiescence-inducing and antiapoptotic activities of IL-15 enhance secondary CD4+ T cell responsiveness to antigen.
    Dooms H; Desmedt M; Vancaeneghem S; Rottiers P; Goossens V; Fiers W; Grooten J
    J Immunol; 1998 Sep; 161(5):2141-50. PubMed ID: 9725205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of mouse CD4 T cell subsets defined by expression of KLRG1.
    Beyersdorf N; Ding X; Tietze JK; Hanke T
    Eur J Immunol; 2007 Dec; 37(12):3445-54. PubMed ID: 18034419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated CD4+CD25+ regulatory T cells inhibit osteoclastogenesis and collagen-induced arthritis.
    Kelchtermans H; Geboes L; Mitera T; Huskens D; Leclercq G; Matthys P
    Ann Rheum Dis; 2009 May; 68(5):744-50. PubMed ID: 18480308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of highly suppressive adaptive CD8(+)CD25(+)FOXP3(+) regulatory T cells by continuous antigen stimulation.
    Mahic M; Henjum K; Yaqub S; Bjørnbeth BA; Torgersen KM; Taskén K; Aandahl EM
    Eur J Immunol; 2008 Mar; 38(3):640-6. PubMed ID: 18266270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mast cells down-regulate CD4+CD25+ T regulatory cell suppressor function via histamine H1 receptor interaction.
    Forward NA; Furlong SJ; Yang Y; Lin TJ; Hoskin DW
    J Immunol; 2009 Sep; 183(5):3014-22. PubMed ID: 19667094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly efficient expansion of human CD4+CD25+ regulatory T cells for cellular immunotherapy in patients with graft-versus-host disease.
    Karakhanova S; Munder M; Schneider M; Bonyhadi M; Ho AD; Goerner M
    J Immunother; 2006; 29(3):336-49. PubMed ID: 16699377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.